Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

• Published in: Clinical ophthalmology (Auckland, N.Z.) Vol. 2; no. 4; pp. 773 - 780
• Main Authors: Ghazi, Nicola G, Conway, Brian P, Tiedeman, James S, Yoon, Steven J
• Format: Journal Article
• Language: English
• Published: New Zealand Taylor & Francis Ltd 01.12.2008; Dove Press; Dove Medical Press
• Subjects: age-related macular degeneration; choroidal neovascularization; classic choroidal neovascularization; disciform scarring; fluorescein angiography; Ophthalmology; Original Research; Photodynamic therapy; classic choroidal neovascularization; disciform scarring; fluorescein angiography; choroidal neovascularization; age-related macular degeneration; photodynamic therapy
• ISSN: 1177-5467; 1177-5483; 1177-5483
• DOI: 10.2147/OPTH.S3653

To emphasize the effect of photodynamic therapy (PDT) on the size and progression of the neovascular lesion (NL) and evolution of the disciform scar (DS) in predominantly classic subfoveal choroidal neovascularization (SFCNV). A retrospective study of 62 eyes treated with PDT for SFCNV was performed. The greatest linear dimension (GLD) before and at last follow-up after treatment and the size of the DS post-PDT were analyzed. A subgroup of patients with DS in their fellow eye at presentation without prior PDT was also studied. The size of the scar in these eyes was compared to that following PDT. After an average follow-up at 9 months, the size of the NL was stabilized or reduced in 64% of the study eyes with absence of fluorescein leakage in 45%. Only 3 eyes (5%) developed DS. At presentation, 14 patients already had DS in their fellow eye, the size of which was significantly larger than that post-PDT (p = 0.044). It was also significantly larger than that of the potential scar in the study eyes of the same subgroup of patients (p = 0.002) and of the rest of the patients (p = 0.0001). This study demonstrates a beneficial effect for PDT on the size of the NL and DS in SFCNV, which might be of great significance, particularly when PDT fails to prevent severe vision loss.